✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Abacavir sulfate; lamivudineis the generic ingredient in four branded drugs marketed by Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla, Laurus, Lupin Ltd, Teva Pharms Usa, Zydus Pharms, and Viiv Hlthcare, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.
Eight suppliers are listed for this compound. There are five tentative approvals for this compound.
Summary for abacavir sulfate; lamivudine
Recent Clinical Trials for abacavir sulfate; lamivudine
Identify potential brand extensions & 505(b)(2) entrants
|ViiV Healthcare||Phase 4|
|Gilead Sciences||Phase 3|
Generic filers with tentative approvals for ABACAVIR SULFATE; LAMIVUDINE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.